0001209191-22-032617.txt : 20220527
0001209191-22-032617.hdr.sgml : 20220527
20220527170145
ACCESSION NUMBER: 0001209191-22-032617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220526
FILED AS OF DATE: 20220527
DATE AS OF CHANGE: 20220527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Myers Scott Dunseth
CENTRAL INDEX KEY: 0001356256
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 22978711
MAIL ADDRESS:
STREET 1: C/O CASCADIAN THERAPEUTICS, INC.
STREET 2: 3101 WESTERN AVE., SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 900
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 900
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-26
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001356256
Myers Scott Dunseth
C/O DYNAVAX TECHNOLOGIES CORPORATION
2100 POWELL STREET, SUITE 900
EMERYVILLE
CA
94608
1
0
0
0
Restricted Stock Unit
2022-05-26
4
A
0
4018
A
Common Stock
4018
4018
D
Stock Option (Right to Buy)
11.68
2022-05-26
4
A
0
16875
A
2029-05-25
Common Stock
16875
16875
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred until the Reporting Person no longer provides services to the Company.
This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date.
Not applicable.
Scott Myers, by /s/ Trevor Dutcher, Attorney-in-Fact
2022-05-27